Interestingly, miR-302a/b/c/d has been shown to reverse the MDR phenotype in BC cells by indirectly repressing P-gp following Mitogen-activated protein kinase kinase kinase 1 (MEKK1) targeting in the extracellular-signal-regulated kinase (ERK) pathway [25]. Here, MAPK1 is linked to breast cancer.